Urology
Volume 54, Issue 6 , Pages 1120-1125 , December 1999

Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins

  • Tara Nickerson

      Affiliations

    • Department of Medicine, McGill University, Montreal, Quebec, Canada
    • ,
  • Michael Pollak

      Affiliations

    • Department of Medicine, McGill University, Montreal, Quebec, Canada
    • Department of Oncology, McGill University, Montreal, Quebec, Canada
    • Lady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada
    • Corresponding Author InformationReprint requests: Michael Pollak, M.D., Lady Davis Institute, 3755 Côte Ste. Catherine Road, Montreal, Quebec H3T 1E2, Canada

Received 15 April 1999 ,Revised 28 June 1999 ,Accepted 28 June 1999.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was supported in part by a grant from the National Cancer Institute of Canada to Michael Pollak

PII: S0090-4295(99)00421-5

Urology
Volume 54, Issue 6 , Pages 1120-1125 , December 1999

Article Tools

* Image Usage & Resolution